CXCL16-driven CD4 + T cells orchestrate immunosurveillance against MHC-I-deficient hepatocellular tumors

免疫系统 癌症研究 免疫监视 下调和上调 趋化因子 肿瘤微环境 生物 细胞毒性T细胞 流式细胞术 主要组织相容性复合体 T细胞 免疫学 PD-L1 基因敲除 小发夹RNA 免疫疗法 CXCL16型 小干扰RNA RNA干扰 基因剔除小鼠 先天免疫系统 质量细胞仪 自然杀伤性T细胞 肿瘤进展 CD8型 炎症 树突状细胞 白细胞介素12 细胞生物学 转录组 化学 信号转导 白细胞介素21 CCL5 细胞 癌细胞 干扰素γ 髓源性抑制细胞
作者
Yunyi Zhou,Ping Chen,Zhixue Wang,Liming Gui,Zhengheng Zheng,Wei‐Qiang Gao,Bin Ma
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:14 (5): e012347-e012347
标识
DOI:10.1136/jitc-2025-012347
摘要

Background Major histocompatibility complex class I (MHC)-I loss is a prevalent mechanism for immune evasion and resistance to immunotherapy. However, how MHC-I loss shapes the tumor microenvironment and influences immune cell interactions, ultimately affecting tumor growth, remains largely unknown. Methods We established B2m knockout (MHC-I-deficient) tumor cells using CRISPR/Cas9 and evaluated their growth in subcutaneous and orthotopic mouse models. Immune profiling was performed using flow cytometry and single-cell RNA sequencing. Antibody-mediated cell depletion was used to assess the functional contributions of specific immune subsets. Chemokine expression was analyzed by bulk RNA sequencing, quantitative PCR, ELISA and western blotting, and its functional relevance was determined using knockout or overexpression in tumor cells implanted in vivo. Signaling pathways were interrogated using pharmacological inhibition, RNA interference and western blotting. Results MHC-I loss promoted tumor growth in MC38, AKR, and LLC1 models, but unexpectedly suppressed Hepa1-6 and orthotopic MYC;Trp53 −/− hepatocarcinoma growth. This differential effect correlated with changes in immune infiltrates. CD4 + T cells, natural killer (NK) cells, and macrophages were required for suppression of MHC-I-deficient Hepa1-6 tumors. CD4 + T cells were essential for recruiting NK cells and monocytes/macrophages and for inducing their tumoricidal phenotypes, including iNOS (inducible nitric oxide synthase) expression in macrophages. The differential infiltration of CD4 + T cells was driven by opposite regulation of CXCL16 on B2m knockout: upregulation in Hepa1-6 cells and downregulation in other models. CXCL16 exerted potent antitumor effects by recruiting CD4 + T cells. Mechanistically, B2M loss regulated CXCL16 via suppression of Akt in MC38 and AKR cells, but via activation of NF-κB in Hepa1-6 cells. Conclusion CXCL16-driven CD4 + T cells are central regulators of antitumor immunity against MHC-I-deficient tumors. The context-dependent regulation of CXCL16 by MHC-I loss determines the immune landscape and tumor outcome, highlighting a potential therapeutic avenue for targeting MHC-I-deficient cancers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Therealyori完成签到 ,获得积分10
刚刚
Lc完成签到 ,获得积分10
1秒前
wyn发布了新的文献求助10
1秒前
yydragen发布了新的文献求助30
1秒前
1秒前
123完成签到,获得积分10
1秒前
飘逸秋荷完成签到,获得积分10
1秒前
可爱的函函的应助被wty采纳,获得10
1秒前
2秒前
安静静槐完成签到,获得积分10
2秒前
2秒前
英俊的铭的应助被Ss采纳,获得10
3秒前
机智白枫发布了新的文献求助10
3秒前
GT完成签到,获得积分20
4秒前
WWW发布了新的文献求助10
4秒前
ELITOmiko发布了新的文献求助10
4秒前
地震学牛马完成签到,获得积分10
4秒前
秋风的应助被DW采纳,获得10
4秒前
轻松雅青发布了新的文献求助10
4秒前
emmm完成签到,获得积分10
5秒前
8秒前
思源的应助被yydragen采纳,获得10
9秒前
科研你好科研再见完成签到,获得积分10
9秒前
10秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
10秒前
10秒前
李健的应助被科研通管家采纳,获得10
10秒前
10秒前
orixero的应助被科研通管家采纳,获得10
10秒前
ding的应助被科研通管家采纳,获得50
11秒前
小马甲的应助被科研通管家采纳,获得10
11秒前
小蘑菇的应助被科研通管家采纳,获得10
11秒前
11秒前
华仔的应助被科研通管家采纳,获得10
11秒前
田様的应助被科研通管家采纳,获得10
11秒前
SciGPT的应助被科研通管家采纳,获得10
11秒前
11秒前
yn完成签到,获得积分10
12秒前
科目三的应助被科研通管家采纳,获得10
12秒前
情怀的应助被科研通管家采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188339
求助须知:如何正确求助?哪些是违规求助? 9576114
关于积分的说明 21845532
捐赠科研通 7786371
什么是DOI,文献DOI怎么找? 3435279
关于科研通互助平台的介绍 2559581
邀请新用户注册赠送积分活动 2482182